Related Experiment Video
Updated: May 26, 2026
08:09
Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
Published on: July 25, 2017
[Synchronous primary endometrial and fallopian tube cancers: one case report]
Huan Wang1, Song-shu Xiao, Fei Zeng
1Department of Gynecology and Obstetrics, Central South University, Changsha, China. wanghuan_wh@163.com
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University
|December 28, 2011
Summary
This case study highlights a rare instance of synchronous primary endometrial and fallopian tube cancer. Laparoscopic surgery and chemotherapy proved effective for this stage I diagnosis.
Area of Science:
- Gynecologic Oncology
- Surgical Pathology
- Chemotherapy Research
Background:
- Menopause and abnormal uterine bleeding are common, but synchronous primary cancers are rare.
- Early detection and accurate staging are crucial for gynecologic malignancies.
- Understanding rare tumor presentations aids in refining treatment protocols.
Observation:
- A patient presented with postmenopausal bleeding and abdominal pain.
- Gynecological exam showed uterine atrophy; imaging and tumor markers (CA125, CEA) were normal.
- Laparoscopic surgery revealed stage Ia synchronous primary cancers in the endometrium and right fallopian tube.
Findings:
- Pathological confirmation of simultaneous primary endometrial and fallopian tube cancers.
- Successful surgical resection via laparoscopically assisted vaginal hysterectomy with bilateral salpingo-oophorectomy.
- Complete remission achieved after 6 cycles of adjuvant chemotherapy (oxaliplatin and docetaxel).
Implications:
- Synchronous primary endometrial and fallopian tube cancer is a rare but treatable condition.
- Minimally invasive surgery offers a viable approach for early-stage disease.
- Adjuvant chemotherapy demonstrates efficacy in preventing recurrence for stage I synchronous cancers.
